AtriCure (ATRC) Reports In-Line Q2 EPS, provides guidance
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $28.44 --0%
Revenue Growth %: +11.7%
Financial Fact:
Income tax expense (benefit): 2K
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: +11.7%
Financial Fact:
Income tax expense (benefit): 2K
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.17), in-line with the analyst estimate of ($0.17). Revenue for the quarter came in at $116.3 million versus the consensus estimate of $116.18 million.
GUIDANCE:
AtriCure sees FY2024 EPS of ($0.74)-($0.82), versus the consensus of ($0.77). AtriCure sees FY2024 revenue of $456-461 million, versus the consensus of $461.9 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
- After-Hours Stock Movers: FDX, CBRS, NKE
- Cboe launches binary options suite tied to Mini-S&P 500 Index
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
